Stay updated on Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial
Sign up to get notified when there's something new on the Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial page.

Latest updates to the Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial page
- Check4 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoChange DetectedA site-wide NIH notice was added announcing updates about the agency’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check18 days agoChange DetectedThe site revision marker changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check25 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check46 days agoChange DetectedThe study page now displays a 403 Forbidden error, blocking access to the trial details. The surrounding site chrome (header/footer and navigation) remains visible, indicating an access issue rather than a data update.SummaryDifference17%

- Check67 days agoChange DetectedThe page footer now displays Revision: v3.6.6, replacing v3.6.5, indicating a lightweight software/UI update to the ClinicalTrials.gov page.SummaryDifference0.0%

Stay in the know with updates to Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Dose-Finding in GH-Deficient Pre-Pubertal Children Clinical Trial page.